Fibrinolysis, inflammation, and regulation of the plasminogen activating system

被引:96
作者
Medcalf, R. L. [1 ]
机构
[1] Monash Univ, Australian Ctr Blood Dis, AMREP, Melbourne, Vic 3004, Australia
关键词
fibrinolysis; gene regulation; inflammation; mRNA stability; transcription;
D O I
10.1111/j.1538-7836.2007.02464.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The maintenance of a given physiological process demands a coordinated and spatially regulated pattern of gene regulation. This applies to genes encoding components of enzyme cascades, including those of the plasminogen activating system. This family of proteases is vital to fibrinolysis and dysregulation of the expression pattern of one or more of these proteins in response to inflammatory events can impact on hemostasis. Gene regulation occurs on many levels, and it is apparent that the genes encoding the plasminogen activator (fibrinolytic) proteins are subject to both direct transcriptional control and significant post-transcriptional mechanisms. It is now clear that perturbation of these genes at either of these levels can dramatically alter expression levels and have a direct impact on the host's response to a variety of physiological and pharmacological challenges. Inflammatory processes are well known to impact on the fibrinolytic system and to promote thrombosis, cancer and diabetes. This review discusses how inflammatory and other signals affect the transcriptional and post-transcriptional expression patterns of this system, and how this modulates fibrinolysis in vivo.
引用
收藏
页码:132 / 142
页数:11
相关论文
共 159 条
[1]  
Agirbasli M, 2006, CLIN EXP RHEUMATOL, V24, P580
[2]   Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease [J].
Alessi, MC ;
Peiretti, F ;
Morange, P ;
Henry, M ;
Nalbone, G ;
JuhanVague, I .
DIABETES, 1997, 46 (05) :860-867
[3]   Degradation of maternal mRNA in mouse embryos: selective degradation of specific mRNAs after fertilization [J].
Alizadeh, Z ;
Kageyama, S ;
Aoki, F .
MOLECULAR REPRODUCTION AND DEVELOPMENT, 2005, 72 (03) :281-290
[4]   Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2α-related factor [J].
Allgayer, H ;
Wang, H ;
Wang, Y ;
Heiss, MM ;
Bauer, R ;
Nyormoi, O ;
Boyd, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :4702-4714
[5]  
ALTUS MS, 1991, J BIOL CHEM, V266, P21190
[6]   Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: Localization of an upstream transcriptional silencer [J].
Antalis, TM ;
Costelloe, E ;
Muddiman, J ;
Ogbourne, S ;
Donnan, K .
BLOOD, 1996, 88 (10) :3686-3697
[7]   Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro [J].
Arts, J ;
Herr, I ;
Lansink, M ;
Angel, P ;
Kooistra, T .
NUCLEIC ACIDS RESEARCH, 1997, 25 (02) :311-317
[8]   On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1α in HepG2 cells [J].
Arts, J ;
Grimbergen, J ;
Toet, K ;
Kooistra, T .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (01) :39-46
[9]  
BACHMANN F, 1995, THROMB HAEMOSTASIS, V74, P172
[10]   PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR [J].
BAJZAR, L ;
MANUEL, R ;
NESHEIM, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14477-14484